Stem cell institute, Evotec target amyotrophic lateral sclerosis

09/12/2013 | GenomeWeb Daily News (free registration)

Evotec and the Harvard Stem Cell Institute will collaborate in the discovery of compounds that inhibit the loss of motor neurons, which has been linked to amyotrophic lateral sclerosis. The partners will use tests based on ALS patient-derived induced pluripotent stem cells that were developed by two faculty members of the institute.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
San Jose, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA